Anxiolytic and antidepressant-like effects of Garum Armoricum® (GA), a blue ling fish protein autolysate in male wistar rats

Current Topics in Nutraceutical Research

Volumn 6, Issue 3, 2008, Pages 115-123

  Messaoudi, Michaël ^a   Nejdi, Amine ^a   Bisson, Jean François ^a   Rozan, Pascale ^a   Javelot, Hervé ^a,b   Lalonde, Robert ^c,d  

^a ETAP Applied Ethology   (France)

^b Hôpital Psychiatrique EPSAN   (France)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d UNIVERSITÉ DE ROUEN   (France)

Author keywords

Anxiety; Conditioned defensive burying; Conditioned place preference; Depression; Fish protein enzymatic autolysate; Forced swimming test; Rat

Indexed keywords

ANXIOLYTIC AGENT; DIAZEPAM; GARUM ARMORICUM; IMIPRAMINE; STABILIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FISH; MALE; NONHUMAN; PLACE PREFERENCE; RAT; SCORING SYSTEM; SWIMMING; TRANQUILIZING ACTIVITY;

MOLVA DIPTERYGIA; RATTUS; RATTUS NORVEGICUS;

EID: 58149385588     PISSN: 15407535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (85)

1. Anisman, H., Zacharko, R.M. (1992) Depression as a consequence of inadequate neurochemical adaptation in response to stressors. British Journal of Psychiatry Suppl. 15, 36-43.
2. Anisman, H., Zacharko, R.M. (1990) Multiple neurochemical and behavioral consequences of stressors: implications for depression. Pharmacology & Therapeutics 46, 119-136.
3. Arteel, G.E., Sies, H. (1999) Protection against peroxynitrite in cocoa polyphenols oligomers. FEBS letters 462, 167-170.
4. Bernet, F., Montel, V., Noel, B., Dupouy, J.-P. (2000) Diazepam-like effects of a fish protein hydrolysate on stress responsiveness of the rat pituitary-adrenal system and sympatho-adrenal activity. Psychopharmacology 149, 34-40.
5. Bond, A.J. (1998) Drug-induced behavioural disinhibition-incidence, mechanisms and therapeutic implications. CNS Drugs 9, 41-57.
6. Buller, R., Legrand, V. (2001) Novel treatments for anxiety and depression: hurdles in bringing them to the market. Drug Discovery Today 6, 1220-1230.
7. Calhoun, S.R., Wesson, D.R., Galloway, G.P., Smith, D.E. (1996) Abuse of flunitrazepam (Rohypnol) and other benzodiazepines in Austin and soudi Texas. Journal of Psychoacive Drugs 28, 183-189.
8. Campos, A.R., Barros, A.I., Albuquerque, F.A.M., Leal, L.K., Rao, V.S. (2005) Acute effects of guarana (Paullinia cupana Mart.) on mouse behaviour in forced swimming and open field tests. Phytotherapy Research 19, 441-443.
9. Chambers, C.D., Hernandez-Diaz, S., Van Marter, L.-J., Werler, M.M., Louik, C., Jones, K. .L, Mitchell, A.A. (2006) Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn., New England Journal of Medicine, 354, 579-587.
10. Crocq, L., Bugard, P., Viaud, P. (1978) Fatigue study group inquiry into asthenia in general practice. Psychologie Médicale (Paris) 10, 1943-1953.
11. Cryan, J.-F., Markou, A., Lucki, I. (2002) Assessing antidepressant activity in rodents: recent developments and future needs. Trends in Pharmacological Sciences 23, 238-245.
12. Cryan, J.-F., Valentino, R.J., Lucki, I. (2005) Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neuroscience and Biobehavioral Reviews 29, 547-569.
13. De Boer, S.F., Koolhaas, J.-M. (2003) Defensive burying in rodents: ethology, neurobiology and psychopharmacology. European Journal of Pharmacology 463, 145-161.
14. Deakin, J.B., Aitken, M.R., Dowson, J.H., Robbins, T.W., Sahakian, B.J. (2004) Diazepam produces disinhibitory cognitive effects in male volunteers. Psychopharmacology 173, 88-97.
15. Delarue, J., Matzinger, O., Binnert, C., Schneiter, P., Chioléro, R., Tappy, L. (2003) Fish oil prevents the adrenal activation elicited by mental stress in healthy men. Diabetes & Metabolism 29, 289-295.
16. Do Rego, J.C., Benkiki, N., Chosson, E., Kabouche, Z., Seguin, E., Costentin, J. (2007) Antidepressant-like effect of hyperfoliatin, a polyisoprenylated phloroglucinol derivative from Hypericum perfoliatum (Clusiaceae) is associated with an inhibition of neuronal monoamines uptake. European Journal of Pharmacology 569, 197-203.
17. Dorman, T., Bemard, L., Glaze, P., Hogan, J., Skinner, R., Nelson, D., Bowker, L., Head, D. (1995) The effectiveness of Garum Amoricum (Stabilium) on reducing anxiety in college students. Journal of Advanced Medicine 8, 193-200.
18. Fava, M., Kendler, K.S. (2000) Major depressive disorder. Neuron 28, 335-341.
19. Fedorova, I., Salem, N Jr. (2006) Omega-3 fatty acids and rodent behavior. Prostaglandins, Leukotrienes and Essential Fatty Acids 75, 271-289.
20. File, S.E. (1986) Aversive and appetitive properties of anxiogenic and anxiolytic agents. Behavioural Brain Research 21, 189-194.
21. Gelenberg, A.J., Wojcik, J.D., Growdon, J.H., Sved, A.F., Wurtman, R.J. (1980) Tyrosine treatment of depression. American Journal of Psychiatry 137, 622-623.
22. Geller, S.E., Studee, L. (2007) Botanical and dietary supplements for mood and anxiety in menopausal women. Menopause 14, 541-549.
23. Gray, S.L., Hanlon, J.T., Landerman, L.R., Artz, M., Schmader, K.E., Fillenbbaum, G.G. (2003) Is antioxidant use protective of cognitive function in the community dwelling elderly? American Journal of Geriatric Pharmacotherapy 1, 3-10.
24. Grundman, M., Delaney, P. (2002) Antioxidant strategies for Alzheimer's disease. Proceedings of the Nutrition Society 61, 191-202.
25. Haag, M. (2003) Essential fatty acids and the brain. Canadian Journal of Psychiatry 48, 195-203.
26. Hamazaki, K., Itomura, M., Huan, M., Nishizawa, H., Sawazaki, S., Tanouchi, M., Watanabe, S., Hamazaki, T., Terazawa, K., Yazawa, K. (2005) Effect of omega-3 fatty acid containing phospholipids on blood catecholamine concentrations in healthy volunteers: a randomized, placebo-controlled, double-blind trial. Nutrition 21, 705-710.
27. Hamazaki, K., Sawazaki, S., Nagasawa, T., Nagao, Y., Kanagawa, Y., Yazawa, K. (1999) Administration of docosahexaenoic acid influences behavior and plasma catecholamine levels at times of psychological stress. Lipids 34, S33-S37.
28. Hamazaki, T., Itomura, M., Sawazaki, S., Nagao, Y. (2000) Antistress effects of DHA. Biofactors 13, 41-45.
29. Henderson, M., Glozier, N., Holland Elliott, K. (2005) Long term sickness absence. British Medical Journal, 330, 802-803.
30. Horrobin, D.F., Bennett, C.N. (1999a) New gene targets related to schizophrenia and other psychiatric disorders: enzymes, binding proteins and transport proteins involved in phospholipid and fatty acid metabolism. Prostaglandins, Leukotrienes and Essential Fatty Acids 60, 141-167.
31. Horrobin, D.F., Bennett, C.N. (1999b) Depression and bipolar disorder: relationships to impaired fatty acid and phospholipid metabolism and to diabetes, cardiovascular disease, immunological abnormalities, cancer, ageing and osteoporosis. Possible candidate genes. Prostaglandins, Leukotrienes and Essential Fatty Acids 60, 217-234.
32. Hu, P., Bretsky, P., Crimmins, E.M., Guralnik, J.-M., Reuben, D.B., Seeman, T.E. (2006) Association between serum beta-carotene levels and decline of cognitive function in high-functioning older persons with or without apolipoprotein E 4 alleles: MacArthur studies of successful aging. Journals of Gerontology Series A: Biological Sciences and Medical Sciences 61, 616-620.
33. Irmisch, G., Schläfke, D., Gierow, W., Herpertz, S., Richter, J. (2007) fatty acids and sleep in depressed inpatients. Prostaglandins, Leucotrienes and Essential Fatty Acids 76, 1-7.
34. Joseph, J.A., Shukitt-Hale, B., Denisova, N., Bielinski, D.F., Martin, A., McEwen, J.J., Bickford, P.C. (1999) Reversals of age-related declines in neuronal signal transduction, cognitive, and motor behavorial deficits with blueberry, spinach, or strawberry dietary supplementation. The Journal of Neuroscience 19, 8114-8121.
35. Joseph, J.A., Shukitt-Hale, B., Denisova, N., Prior, R.L., Cao, G., Martin, A., Taglialatela, G., Bickford, P.C. (1998) Long- term dietary strawberry, spinach, or vitamin E supplementation retards the onset of age-related neuronal signal-transduction and cognitive behavorial deficits. The Journal of Neuroscience 18, 8047-8055.
36. Kalkunte, S.S., Singh, A.P., Chaves, F.C., Gianfagna, T.J., Pundir, V.S., Jaiswal, A.K., Vorsa, N., Sharma, S. (2007) Antidepressant and antistress activity of GC-MS characterized lipophilic extracts of Ginkgo biloba leaves. Phytotherapy Research 21, 1061-1065.
37. Kitada, Y., Miyauchi, T., Satoh, A., Satoh, S. (1981) Effects of antidepressants in the rat forced swimming test. European Journal of Pharmacology 72, 145-152.
38. Kong, W.X., Chen, S.W., Li, Y.L., Zhang, Y.J., Wang, R., Min, L., Mi, X. (2006) Effects of taurine on rat behaviors in three anxiety models. Pharmacology Biochemistry and Behavior 83, 271-276.
39. Lakhwani, L., Tongia, S.K., Pal, V.S., Agrawal RP, Nyaati P & Phadnis (2007) Omega-3 fatty acids have antidepressant activity in forced swimming test in Wistar rats. Acta Poloniae Pharmaceutica 64, 271-276.
40. Lane, S.D., Tcheremissine, O.V., Living, L.M., Nouvion, S., Cherek, D.R. (2005) Acute effects of alprazolam on risky decision making in humans. Psychopharmacology 181, 364-373.
41. Lin, P.Y., Su, K.P. (2007) A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. Journal of Clinical Psychiatry 68, 1056-1561.
42. McDonalds, S., Wells, S., Giesbrecht, N., Cherpitel, C.J. (1999) Demographic and substances use factors related to violent and accidental injuries: results from an emergency room study. Drug and Alcohol Dependence 55, 53-61.
43. McKenna, D.J., Jones, K., Humphrey, S., Hughes, K. (2001) Black cohosh: efficacy, safety, and use in clinical and preclinical applications. Alternative Therapies in Health and Medicine 7, 93- 100.
44. Messaoudi, M., Lefranc-Millot, C., Desor, D., Demagny, B. Bourdon, L. (2005) Effects of a tryptic hydrolysate from bovine milk alpha S1-casein on hemodynamic responses in healthy human volunteers facing successive mental and physical stress situations. European Journal of Nutrition 44, 128-132.
45. Miclo, L., Perrin, E., Driou, A., Papadopoulos, V., Boujrad, N., Vanderesse, R., Boudier, J.-F., Desor, D., Linden, G. Gaillard, J.-L. (2001) Characterization of á casozepine, a tryptic peptide from bovine alpha S1-casein with benzodiazepine-like activity. FASEB Journal 15, 1780-1802.
46. Miyasaka, L.S., Atallah, A.N., Soares, B.G. (2007) Passiflora for anxiety disorder. Cochrane Database of Systematic Reviews 1, CD004518.
47. Montgomery, S.A. (1995) Rapid onset of action of venlafaxine. International Clinical Psychopharmacology 10 Suppl 2, 21-27.
48. Mora, S., Díaz-Véliz, G., Millán, R., Lungenstrass, H., Quirós, S., Coto-Morales, T., Hellión-Ibarrola, M.C. (2005) Anxiolytic and antidepressant-like effects of the hydroalcoholic extract from Aloysia polystachya in rats. Pharmacology Biochemistry and Behavior 82:373-378.
49. Mora, S., Millán, R., Lungenstrass, H., Díaz-Véliz, G., Morán, J.A., Herrera-Ruiz, M., Tortoriello, J. (2006) The hydroalcoholic extract of Salvia elegans induces anxiolytic and antidepressant-like effects in rats. Journal of Ethnopharmacology 106, 76-81.
50. Morris, M.C., Evans, D.A., Bienias, J.-L., Tangney, C.C., Wilson, .S. (2002) Vitamin E and cognitive decline in older persons. Archives of Neurology 59, 1125-1132.
51. Morris, M.C., Evans, D.A., Tangney, C.C., Bienias, J.-L., Wilson, R.S. (2005) Fish consumption and cognitive decline with age in a large community study. Archives of Neurology 62, 1849-1853.
52. Moussavi, S., Chatterji, S., Verdes, E., Tandon, A., Patel, V. Ustun, B. (2007) Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 370, 851-858.
53. Nystuen, P., Hagen, K.B., Herrin J (2001) Mental health problems as a cause of long term sick leave in the Norwegian workforce. Scandinavian Journal of Public Health 29, 175-182.
54. Otobone, F.J., Sanches, A.C., Nagae, R., Martins, J.V., Sela, V.R., de Mello, J.-C., Audi, E.A. (2007) Effect of lyophilized extracts from guaraná seeds [Paullinia cupana var. sorbilis (Mart.) Ducke] on behavioral profiles in rats. Phytotherapy Research 21, 531-535.
55. Perrig, W.J., Perrig, P., Stahelin, H.B. (1997) The relation between antioxidants and memory performances in the old and very old. Journal of American Geriatric Society 45, 718-724.
56. Pinel, J.-P., Treit, D. (1978) Burying as a defensive response in rats. Journal of Comparative Physiology and Psychology 92, 708-712.
57. Porsolt, R.D. (1981) Behavioral despair. In Enna, SJ (ed) Antidepressants: neurochemical, behavioral and clinical perspectives. Raven Press, New York, pp. 121-139.
58. Porsolt, R.D., Anton, G., Daniel, M. (1978) Behavioral despair in rats: a new model sensitive to antidepressant treatments. European Journal of Pharmacology 17, 379-391.
59. Porsolt, R.D., Epichon, M., Jalfre, M. (1977) Depression: a new animal model sensitive to antidepressant treatments. Nature 266, 730-732.
60. Reinstein, D.K., Lehnert, H., Wurtman, R.J. (1985) Dietary tyrosine suppresses the rise in plasma corticosterone following acute stress in rats. Life Sciences 37, 2157-2163.
61. Rogers, P.-J., Appleton, K.M., Kessler, D. et al. (2008) No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: a randomised controlled trial. British Journal of Nutrition 99, 421-31.
62. Ross, B.M., Seguin, J., Sieswerda, L.E. (2007) Omega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid? Lipids in Health and Disease 6, 21.
63. Rozan, P., Hidalgo, S., Nejdi, A., Bisson, J.-F., Lalonde, R., Messaoudi, M. (2007) Preventive antioxidant effects of cocoa polyphenolic extract on free radical production and cognitive performances after heat exposure in Wistar rats. Journal of Food Sciences 72, S203-S206.
64. Saeed, S.A., Bloch, R.M., Antonacci, D.J. (2007) Herbal and dietary supplements for treatment of anxiety disorders. American Family Physician 76, 549-556.
65. Sakakibara, H., Ishida, K., Grundmann, O., Nakajima, J., Seo, S., Butterweck, V., Minami, Y., Saito, S., Kawai, Y., Nakaya, Y., Terao, J. (2006) Antidepressant effect of extracts from Ginkgo biloba leaves in behavioral models. Biological & Pharmaceutical Bulletin 29, 1767-1770.
66. Sanchez-Villegas, A., Henríquez, P., Figueiras, A., Ortuño, F., Lahortiga, F., Martínez González, M.A. (2007) Long chain omega-3 fatty acids intake, fish consumption and mental disorders in the SUN cohort study. European Journal of Nutrition 46, 337-346.
67. Sarris, J. (2007) Herbal medicines in the treatment of psychiatric disorders: a systematic review. Phytotherapy Research 21, 703-716.
68. Saugstad, L.F. (2006) Are neurodegenerative disoder and psychotic manifestations avoidable brain dysfunctions widi adequate dietary omega-3? Nutrition and Health 18, 89-101.
69. Schroeter, H., Williams, J.R., Matin, R., Iverson, L., Rice-Evans, C.A. (2000) Phenolic antioxidants attenuate neuronal cell death following uptake of oxidized low-density lipoprotein. Free Radical Biology & Medicine 29, 1222-1233.
70. Sies, H., Stahl, W. (1995) Vitamins E and C, beta-carotene, and other carotenoids as antioxidants. American Journal of Clinical Nutrition 62, 1315S-1321S.
71. Sinclair, A.J., Begg, D., Mathai, M., Weisinger, R.S. (2007) Omega-3 fatty acids and brain: review of studies in depression. Asia Pacific Journal of Clinical Nutrition 16, 391-397.
72. Smriga, M., Torii, K. (2003) Prolonged treatment with L-lysine and L-arginine reduces stress-induced anxiety in an elevated plus maze. Nutritional Neuroscience 6, 125-128.
73. Srinongkote, S., Smriga, M., Nakagawa, K., Toride, Y. (2003) A diet fortified with L-lysine and L-arginine reduces plasma cortisol and blocks anxiogenic response to transportation in pigs. Nutritional Neuroscience 6, 283-289.
74. Takeuchi, T., Iwanaga, M., Harada, E. (2003) Possible regulatory mechanism of DHA-induced anti-stress reaction in rats. Brain Research 964, 136-143.
75. Van Laar, M.W., Volkerts, E.R. (1998) Driving and benzodiazepine use-evidence that they do not mix. CNS Drugs 10, 383-396.
76. Violle, N., Messaoudi, M., Lefranc-Millot, C., Desor, D., Nejdi, A, Demagny, D. Schroeder, H. (2006) Ediological comparison of the effects of a bovine alpha-S1 casein tryptic hydrolysate and diazepam on the behaviour of rats in two models of anxiety. Pharmacology Biochemistry and Behavior 84, 517-523.
77. Walsh, R.N., Cummins, R.A. (1976) The open-field test: a critical review. Psychological Bulletin 83, 482-504.
78. Wang, J.-L., Adair, C.E., Patten SB (2006) Mental health and related disability among workers: A population-based study. American Journal of Industrial Medicine 49, 514-522.
79. Wang, L., Maher, T.J., Wurtman, R.J. (2007) Oral L-glutamine increases GABA levels in striatal tissue and extracellular fluid. FASEB Journal 21, 1227-1232.
80. Wang, P.S., Aguilar-Gaxiola, S., Alonso J. et al.(2007) Use of mental health services for anxiety, mood, and substance disorders in 17 countries in the WHO world mental health surveys. Lancet 370, 841-850.
81. Whiskey, E., Werneke, U. Taylor, D. (2001) A systematic review and meta-analysis of Hypericum perforatum in depression: a comprehensive clinical review. International Clinical Psychopharmacology 16, 239-252.
82. Yehuda, S., Rabinovitz, S., Mostofsky, D.I. ( 2005) Mixture of essential fatty acids lowers test anxiety. Nutritional Neuroscience 8, 265-267.
83. Young, G., Conquer, J. (2005) Omega-3 fatty acids and neuropsychiatric disorders. Reproduction Nutrition Development 45, 1-28.
84. Young, L.S., Bye, R., Scheltinga, M., Ziegler, T.R., Jacobs, D.O., Wilmore, D.W. (1993) Patients receiving glutamine-supplemented intravenous feedings report an improvement in mood. Journal of Parenteral & Enteral Nutrition 17, 422-427.
85. Zhang, C.G., Kim, S.J. (2007) Taurine induces anti-anxiety by activating strychnine sensitive glycine receptor in vivo. Annals of Nutrition and Metabolism 51, 379-386.